Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

Property Value
dbo:abstract
  • Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. (en)
dbo:industry
dbo:location
dbo:numberOfEmployees
  • 500 (xsd:integer)
dbo:thumbnail
dbo:type
dbo:wikiPageEditLink
dbo:wikiPageExternalLink
dbo:wikiPageExtracted
  • 2020-01-17 10:51:26Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 40448087 (xsd:integer)
dbo:wikiPageLength
  • 13851 (xsd:integer)
dbo:wikiPageModified
  • 2020-01-17 10:51:21Z (xsd:date)
dbo:wikiPageOutDegree
  • 51 (xsd:integer)
dbo:wikiPageRevisionID
  • 936209350 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. (en)
rdfs:label
  • Alnylam Pharmaceuticals (en)
owl:sameAs
foaf:depiction
foaf:isPrimaryTopicOf
foaf:name
  • Alnylam Pharmaceuticals Inc. (en)
is dbo:wikiPageRedirects of
is foaf:primaryTopic of